References
Culy CR, Clemett D, Wiseman LR (2000) Oxaliplatin: a review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies. Drugs 60:895–924
de Gramont A, Figer A, Seymour H, Homerin H, Hmissi A, Cassidy J et al (2000) Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18:2938–2947
Goldberg RM, Sargent DJ, Morton RF, Fuchs CS, Ramanathan R, Williamson SK et al (2004) A randomized controlled trial of fluorouracil plus leucovorin, irinotecan and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 22:23–30
Gamelin E, Gamelin L, Bossi L, Quasthoff S (2002) Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and preventive measures. Semin Oncol 29:21–33
Grothey A (2003) Oxaliplatin-safety profile: neurotoxicity. Semin Oncol 30[Suppl 4]:5–13
Wilson RH, Lehky T, Thomas RR, Quinn MG, Floeter HK, Grem JL (2002) Acute oxaliplatin-induced peripheral nerve hyperexitability. J Clin Oncol 20:1767–1774
Hart IK, Waters C, Vincent A, Newland C, Beeson D, Pongs O et al. (1997) Autoantibodies detected to expressed K channels are implicated in neuromyotonia. Ann Neurol 41:238–246
Nagado T, Arimura K, Sonoda Y et al (1999) Potassium current suppression in patients with peripheral nerve hyperexcitability. Brain 122:2057–2066
Webster RG, Brain KL, Wilson RH, Grem JL, Vincent A (2005) Oxaliplatin induces hyperexcitability at motor and autonomic neuromuscular junctions through effects on voltage-gated sodium channels. Br J Pharmacol 146:1027–1039
Frei E, Spindler I, Grissmer S, Jager H (2006) Interactions of N-terminal and C-terminal parts of the small conductance Ca2+ activated K+ channels, hSK3. Cell Physiol Biochem 18:165–176
Grolleau F, Gamelin L, Boisdron-Celle M, Lapied B, Pelhate H, Gamelin E (2001) A possible explanation for a neurotoxic effect of the anticancer agent oxaliplatin on neuronal voltage-gated channels. J Neurophysiol 85:2293–2297
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Basso, M., Cassano, A., Modoni, A. et al. A reversible coma after oxaliplatin administration suggests a pathogenetic role of electrolyte imbalance. Eur J Clin Pharmacol 64, 739–741 (2008). https://doi.org/10.1007/s00228-008-0474-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-008-0474-x